Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Following the cytokine signaling pathway to leukemogenesis: a chronology
Kendall A. Smith, James D. Griffin
Kendall A. Smith, James D. Griffin
Published November 3, 2008
Citation Information: J Clin Invest. 2008;118(11):3564-3573. https://doi.org/10.1172/JCI35819.
View: Text | PDF
Review Series

Following the cytokine signaling pathway to leukemogenesis: a chronology

  • Text
  • PDF
Abstract

Studies over the past 50 years revealing the molecular events that promote normal T lymphocyte cycle competence and progression led to a detailed understanding of how cytokines function to regulate normal hematopoietic cell proliferation. During that same period, the molecular and genetic changes introduced by the Philadelphia chromosome in chronic myelogenous leukemia were unraveled, and these have led to an understanding of how mutations that constitutively activate normal cytokine signaling pathways can cause unregulated cell proliferation and malignant transformation. Based on the paradigm established by these data, it is inescapable that going forward, investigators will operate under the hypothesis that transformation of additional cells and tissues will have a similar pathogenesis.

Authors

Kendall A. Smith, James D. Griffin

×

Figure 2

Structure-function relationships of the receptors controlling T lymphocyte and myeloid cell cycle competence and progression.

Options: View larger image (or click on image) Download as PowerPoint
Structure-function relationships of the receptors controlling T lymphocy...
The TCR activates cytoplasmic kinases (including Lck, ZAP-70, and PLCγ), which signal via intermediates to induce the activation of members of three distinct families of transcription factors, Rel, activator protein–1 (AP1), and nuclear factor of activated T cells (NFAT). These transcription factors then coordinate the expression of the genes encoding IL-2 and the subunits of IL-2R, thereby rendering the cell competent to progress through the cell cycle. Heteromeric cytokine receptors, here represented by IL-2R, are composed of two or three distinct transmembrane chains. Binding of the cytokine to the external receptor chain domains brings the cytoplasmic domains into close enough proximity for their respective receptor-associated JAK molecules to initiate signaling. Subsequently, the activated STAT dimers translocate to the nucleus and initiate transcription of genes encoding proteins such as cyclin D2 (Cyc D) to promote progression beyond the R-point and also genes encoding cell-survival proteins, such as Bcl-XL. By comparison, homomeric receptors already have the same bound JAK molecules in close proximity, and ligand binding readily initiates signaling by promoting transphosphorylation of JAK2, the receptor chains, and eventually STAT5. G-CSFR, G-CSF receptor; EpoR, erythropoietin receptor; TpoR, thrombopoietin receptor.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts